March 30, 2009 – Takeda Pharmaceutical Company Limited announced today that it submitted a New Drug Application to the Ministry of Health, Labour and Welfare for a fixed dose combination of Blopress (generic name: candesartan cilexetil) and amlodipine besylate for treatment of hypertension.
The details can be read here.
No comments:
Post a Comment